New immunohistochemical prognostic factor of uveal melanoma

New immunohistochemical prognostic factor of uveal melanoma

Celkové hodnotenie

Vedecká práca
100%
Prevedenie (dizajn)
80%
Diskusná interakcia
PoužívateľVedecká prácaDizajnDiskusná interakcia
Adriána Furdová100%80%-
ISBN: 978-80-970712-6-4

New immunohistochemical prognostic factor of uveal melanoma

Zuzana Svetlošáková1 , Hana Gergišáková2 , Alena Furdová
1 Department of Ophthalmology, University Hospital Ruzinov, Bratislava, Slovakia
2 Department od Pathological anatomy Comenius University in Bratislava, Faculty of Medicine, Bratislava, Slovakia
zuzana.svetlosakova@gmail.com

Apoptosis-inducing factor (AIF) is a mitochondrial protein, which plays an important role in the caspase-independent apoptosis and has also an oxidoreductase function. The expression of AIF in uveal melanoma and its possible impact on patients` prognosis is unkonwn. The aim of our study was to evaluate the expression of AIF in uveal melanoma cells and to assess its predictive value.

We performed a retrospective study of 54 patients with choroidal or ciliary body melanoma treated surgically (enucleation, endoresection) at our clinic during the years 2001 - 2007. Patients` mortality was assessed to August 30th 2012.  Immunohistochemical evaluation of AIF expression using polyclonal rabbit antibody in formalin-fixed paraffin embedded melanoma tissue was performed.

Histological samples of 49 patients were assessed. During the follow-up of 60 ± 36 months there was a significantly higher mortality in patients with ≥ 70% of immunopositive cells in the histological sample comparing to those with lower or none AIF expression (70,4% vs. 40,9%, P=0,038), while there was no significant difference in known conventional prognostic factors (mean age, tumor size or histopathological type of tumor) between the compared groups.

Our study shows that high level of AIF expression in uveal melanoma cells is associated with unfavourable prognosis. The role of AIF as a prognostic factor in uveal melanoma will need confirmation in larger and prospective studies.

Poďakovanie: 
Zdroje: 
Prezentácia nie je dostupná

Diskusia

Dobrý deň pani doktorka! Chcela by som sa Vás opýtať, že prečo ste vybrali práve AIF vo Vašej štúdii? Uvádzate, že neboli zmeny vo veku, veľkosti tumoru a histologickom type medzi dvoma skupinami. Sledovali ste, či neboli rozdiely vo výskyte metastáz? Neviem, či to dobre rozumiem, ale Vaša práca poukazuje na to, že čím väčšia expresia apoptotického faktora AIF v jadre, tým horšia prognóza. Ja by som očakávala skôr lepšiu prognózu. Je už známy nejaký mechanizmus pôsobenia AIF? Ďakujem!